Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck CancerMarshall R. Posner, Robert I. Haddad, Diáne Hershock et al.|New England Journal of Medicine|2007Cited by 1.7k
Phase III Multicenter Randomized Trial of the Dartmouth Regimen Versus Dacarbazine in Patients With Metastatic MelanomaPaul B. Chapman, John M. Kirkwood, Lawrence H. Einhorn et al.|Journal of Clinical Oncology|1999Cited by 763
Results of a Phase III, Randomized, Placebo-Controlled Study of Sorafenib in Combination With Carboplatin and Paclitaxel As Second-Line Treatment in Patients With Unresectable Stage III or Stage IV MelanomaAxel Hauschild, Ulrich Keilholz, Claus Garbe et al.|Journal of Clinical Oncology|2009Cited by 545
Extended schedule, escalated dose temozolomide versus dacarbazine in stage IV melanoma: Final results of a randomised phase III study (EORTC 18032)Poulam M. Patel, Alan Spatz, Stefan Suciu et al.|European Journal of Cancer|2011Cited by 210
Final results of a phase II multicenter trial of HF10, a replication-competent HSV-1 oncolytic virus, and ipilimumab combination treatment in patients with stage IIIB-IV unresectable or metastatic melanoma.Robert Hans Ingemar Andtbacka, Kenneth F. Grossmann, Merrick I. Ross et al.|Journal of Clinical Oncology|2017Cited by 55